Subjects ” Neurological behavior disorders
Azstarys ™ (serdexmethylphenidate and dexmethylphenidate), a novel treatment for attention deficit hyperactivity disorder (ADHD) in patients 6 years and older, was developed by Corium, Inc.
Azstarys is made from serdexmethylphenidate, a prodrug of dexmethylphenidate that is formulated with immediate release dexmethylphenidate. Each Azstarys capsule contains a fixed molar ratio of 70% serdexmethylphenidate and 30% dexmethylphenidate. The treatment is given once a day in the morning and can either be taken whole or the contents of the capsule can be opened and mixed with water or applesauce.
Azstarys is available in 3 capsule strengths (Serdexmethylphenidate / Dexmethylphenidate): 26.1 mg / 5.2 mg, 39.2 mg / 7.8 mg and 52.3 mg / 10.4 mg. It should not be replaced with other methylphenidate products on a milligram-per-milligram basis as these products have different pharmacokinetic profiles and may have a different methylphenidate-based composition.
Continue reading
Azstarys approval was supported by data from a randomized, double-blind, placebo-controlled, analog classroom study (ClinicalTrials.gov: NCT03292952) that enrolled 150 patients aged 6 to 12 years with ADHD. Azstarys has been shown to be effective in adults and children and adolescents aged 13 to 17 years by pharmacokinetic bridging between Azstarys and prolonged-release dexmethylphenidate hydrochloride capsules.
Azstarys is classified as a List II controlled substance by the US Drug Enforcement Administration.
relation
Corium introduces the innovative ADHD treatment Azstarys ™ (Serdexmethylphenidate and Dexmethylphenidate) for patients 6 years and older in the USA. Press release. Corium, Inc. Accessed July 21, 2021. https://www.prnewswire.com/news-releases/corium-launches-innovative-adhd-treatment-azstarys-serdexmethylphenidate-and-dexmethylphenidate-in-the-us-for – patient-age-6-years-and-older-301338086.html.
This article originally appeared on MPR
Subjects:
Attention Deficit / Hyperactivity Disorder Neurological behavioral disorders
Would you like to read more?
Please log in or register first to view this content.
Login Register
Open
Next post in Neurobehavioral Disorders
Shut down
Include more information on Azstarys, a novel ADHD treatment, now available
Loading… 
Include more information on Azstarys, a novel ADHD treatment, now available
Loading…
Include more information on Azstarys, a novel ADHD treatment, now available
Loading…
Include more information on Azstarys, a novel ADHD treatment, now available
Loading…
Would you like to see more content from Neurology Advisor?
Register now for free to access unlimited clinical news with personalized daily tips for you, Full-length features, case studies, conference reports, and more.
{{login-button}} {{register-button}}
Would you like to read more?
Please log in or register first to view this content.
Login Register
